A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects

Phase 1 Completed 56 enrolled Astellas Pharma Inc Astellas Pharma Taiwan, Inc. · collab

RandomizedParallel-groupQuadruple-blind

Summary

This study assesses the safety, tolerability, pharmacokinetics and pharmacodynamics of ASP1941 orally administered as single doses to healthy adult male Taiwanese subjects.

Timeline

Start: 2011-02
Primary completion: 2011-03
Completion: 2011-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ipragliflozin	Small molecule	—	Oral

Indications

No indication recorded.